Net leverage stood at 2.6 times, near the lower end of Fresenius Medical Care's target range of 2.5 to 3 times. Fresenius Medical Care continues to expect the business to operate around break-even for the full year. About Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)Fresenius Medical Care AG & Co KGaA is the world's largest integrated provider of products and services for individuals with renal diseases. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services. The article "Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights" was originally published by MarketBeat.